Literature DB >> 2749186

Time, context, and subjective experiences in schizophrenia.

M W deVries1, P A Delespaul.   

Abstract

Systematic investigations into the experience of schizophrenic patients as they react and adapt to social environments are rare. Yet such information is extremely useful for understanding the psychopathology of schizophrenia, the planning of treatments, as well as for creating optimal treatment and living environments. In this study, dynamic fluctuations of mental state, social context, and experience in the daily life of schizophrenic patients were measured. Data were collected using the Experience Sampling Method on nine schizophrenic subjects and seven nonpsychiatric controls. Schizophrenic patients spent more time alone than normal--a difference that was largely created by the subsample of outpatients; hospitalized patients were less alone. As a group, the patients felt best when they were with one to three persons. The most troublesome condition reported was being alone or being in the company of more than three people. Three cases are presented to illustrate the individual variability of subjects' experience.

Entities:  

Mesh:

Year:  1989        PMID: 2749186     DOI: 10.1093/schbul/15.2.233

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  9 in total

1.  A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia.

Authors:  Elizabeth Bromley; Gail Fox Adams; John S Brekke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

2.  Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations.

Authors:  Eric Granholm; Dror Ben-Zeev; Peter C Link; Kristen R Bradshaw; Jason L Holden
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 3.  Emotional response deficits in schizophrenia: insights from affective science.

Authors:  Ann M Kring; Erin K Moran
Journal:  Schizophr Bull       Date:  2008-06-25       Impact factor: 9.306

4.  Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study of acceptability, compliance, and reactivity.

Authors:  Elizabeth I Johnson; Olivier Grondin; Marion Barrault; Malika Faytout; Sylvia Helbig; Mathilde Husky; Eric L Granholm; Catherine Loh; Louise Nadeau; Hans-Ulrich Wittchen; Joel Swendsen
Journal:  Int J Methods Psychiatr Res       Date:  2009       Impact factor: 4.035

5.  Testing an mHealth momentary assessment Routine Outcome Monitoring application: a focus on restoration of daily life positive mood states.

Authors:  Jim van Os; Philippe Delespaul; Daniela Barge; Roberto P Bakker
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

6.  Network Approach to Understanding Emotion Dynamics in Relation to Childhood Trauma and Genetic Liability to Psychopathology: Replication of a Prospective Experience Sampling Analysis.

Authors:  Laila Hasmi; Marjan Drukker; Sinan Guloksuz; Claudia Menne-Lothmann; Jeroen Decoster; Ruud van Winkel; Dina Collip; Philippe Delespaul; Marc De Hert; Catherine Derom; Evert Thiery; Nele Jacobs; Bart P F Rutten; Marieke Wichers; Jim van Os
Journal:  Front Psychol       Date:  2017-11-02

7.  Altered Heart Rate Variability in Patients With Schizophrenia During an Autonomic Nervous Test.

Authors:  Ya Liu; Yuanyuan Huang; Jing Zhou; Guixiang Li; Jun Chen; Zhiming Xiang; Fengchun Wu; Kai Wu
Journal:  Front Psychiatry       Date:  2021-03-30       Impact factor: 4.157

8.  Feasibility and validity of computerized ecological momentary assessment in schizophrenia.

Authors:  Eric Granholm; Catherine Loh; Joel Swendsen
Journal:  Schizophr Bull       Date:  2007-10-10       Impact factor: 9.306

9.  Smartphone ownership and interest in mobile applications to monitor symptoms of mental health conditions.

Authors:  John Torous; Rohn Friedman; Matcheri Keshavan
Journal:  JMIR Mhealth Uhealth       Date:  2014-01-21       Impact factor: 4.773

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.